Growth Hormone News and Research

RSS

Growth hormone (GH) is a protein-based peptide hormone. It stimulates growth, cell reproduction and regeneration in humans and other animals. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by the somatotroph cells within the lateral wings of the anterior pituitary gland.

Intermittent fasting may provide significant health benefits, study shows

Intermittent fasting may provide significant health benefits, including improved cardiometabolic health, improved blood chemistry and reduced risk for diabetes, new research conducted in part at Texas State University indicates.

10 Dec 2019

Intermittent fasting – not just a fad for cardiac patients

A new study suggests patients with cardiac catheterization have a longer lifespan if they carry out intermittent fasting.

20 Nov 2019

Cardiac catheterization patients practicing intermittent fasting live longer

While Intermittent fasting may sound like another dieting craze, the practice of routinely not eating and drinking for short periods of time has shown again to lead to potentially better health outcomes.

17 Nov 2019

Two-hormone combo test predicts prostate cancer risk

New research presented at the NCRI Cancer Conference, 2019, shows that free testosterone and insulin-like growth factor-1 (IGF-I), when present at high levels in combination, show a higher risk of prostate cancer in men. This finding is important since both these factors can be counteracted, to possibly reduce the risk.

3 Nov 2019

Study identifies factor essential for tendon growth

Insulin-like growth factor 1 (IGF1) is essential for allowing tendons to adapt to physical activity and grow properly, according to basic science research by investigators at Hospital for Special Surgery.

24 Sep 2019

Long-term follow-up of childhood cancer survivors is essential to maintain bone health

Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%.

3 Jul 2019

Groundbreaking drug boosts growth rates in children with achondroplasia

A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's Murdoch Children's Research Institute.

18 Jun 2019

Researchers study the impact of and treatment for aggrecan deficiency

On Sunday, April 28, a team of researchers received the 2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for their abstract, entitled "Clinical Characterization and Trial of Growth Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented this at the PES Presidential Poster Session.

8 May 2019

Growth hormone acts directly on the brain to conserve energy when the body loses weight

Researchers at the University of São Paulo in Brazil have discovered that growth hormone (GH), which stimulates skeletal maturation and linear bone growth, as well as helping maintain tissue and organs throughout life, also acts directly on the brain to conserve energy when the body loses weight.

12 Apr 2019

Savings from lower insurance costs of growth hormone drugs not passed on to patients

Increasingly aggressive insurance strategies have lowered the total costs and insurance costs of growth hormone drugs, but those savings are not being passed on to patients, according to new research to be presented Sunday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

25 Mar 2019

Study finds increased financial burden for growth hormone treatment despite FDA approval

Despite an FDA approval of growth hormone treatment for children with idiopathic short stature, the mean cost burden to patients and their families has increased over time, according to findings from researchers at Children's Hospital of Philadelphia and the Leonard Davis Institute of Health Economics of the University of Pennsylvania.

25 Mar 2019

Researchers identify regulatory mechanism underlying obesity

Obesity − as research in the past decade has shown − is first and foremost a brain disease. Researchers at Helmholtz Zentrum München, partners in the German Center for Diabetes Research, have now discovered a molecular switch that controls the function of satiety neurons and therefore body weight. The findings were published in the journal 'Nature Metabolism'.

31 Jan 2019

Alzheimer's could possibly be spread via contaminated neurosurgery

Researchers have found that surgical instruments used for neurosurgery could get contaminated by the altered brain proteins that are seen in Alzheimer’s disease. These instruments are capable of spreading the condition if not treated or decontaminated properly before reuse. The study results were published in the latest issue of the journal Nature.

14 Dec 2018

Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer's disease

A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.s

14 Dec 2018

New findings provide better picture of pubertal growth

In monitoring and prediction of children's growth, the spurt in puberty is often considered too variable to be predictable. However, new findings and methods enable a better picture of how children and adolescents grow, especially during puberty.

30 Nov 2018

New synthetic compound based on brain hormone holds promise for cancer treatment

A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.

6 Nov 2018

Unraveling a rare genetic mutation related to growth disorders

What would happen if you suddenly stopped growing at age 12 or 13? Solving genetic growth mysteries and scheduling regular appointments with pediatric endocrinologists is atypical for most parents and pediatricians.

1 Nov 2018

NIH funding will allow four pediatric health systems to study causes of growth disorders

The National Institutes of Health awards Andrew Dauber, M.D., MMSc, the chief of endocrinology at Children's National Health System, a five-year grant that will allow four pediatric health systems to compile and study clinical and genetic markers of severe pediatric growth disorders.

31 Oct 2018

Estrogens found in cows’ milk shown to pose no risk to adult health

A review of studies looking into the health effects of estrogen-containing cows’ milk has found that the milk is likely to be safe for human consumption.

26 Oct 2018